Spero Health Opens Cookeville Clinic

Spero Health, a CARF-accredited organization and leader in outpatient addiction treatment, has announced the opening of a new clinic in Cookeville, Tennessee. The Cookeville Spero Health Clinic located at 225 N Willow Ave. will open on Friday, November 22nd and will begin seeing patients that day. For more information or to schedule an immediate appointment, individuals are encouraged to call the clinic at (931) 303-0889. Dr. Harold Alan Chertok has joined the organization as the medical director and lead physician at this clinic. Board-certified in Family Medicine and board-eligible in Addiction Medicine, Dr. Chertok has a long history of providing treatment for substance use disorders in Cookeville, and shares Spero’s philosophy that an integrated approach to addiction treatment leads to long term success and positive outcomes in recovery.

Spero Health provides local and affordable care for more than 6,000 fellow human beings throughout Kentucky, Indiana Ohio and Tennessee. They accept TennCare and most commercial insurance plans so that cost is not a barrier to addiction treatment.

In the last decade more than 650,000 people have died from a drug overdose, according to the Center for Disease Control. “As the numbers of individuals who die as a result of substance use disorders continues to worsen, it is more critical now than ever that our communities have access to a local, high quality solution to address the needs right there at home.” said Steve Priest, CEO. “Our team is not only focused on saving lives, but on helping strengthen the communities that we serve. It is our desire to be an active member of the local healthcare community and a partner in the fight against this deadly disease.”

“Substance use disorders are treatable but there isn’t a one-size fits all solution, which is why Spero Health considers each unique patient need when developing treatment plans and setting goals for the future,” said Dr. Chertok. “Spero Health’s approach is designed to provide rapid access to care and allow individuals to remain in their communities throughout treatment so they can continue working and caring for their families, which ultimately enhances their quality of life.”